P53 induction and apoptosis in response to radio-and chemotherapy in vivo is tumor-type-dependent

Cancer Research

Volumn 61, Issue 1, 2001, Pages 327-332

  Kemp, C J ^a   Sun, S ^a   Gurley, K E ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADENOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; DNA DAMAGE; IN VIVO STUDY; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; T CELL LYMPHOMA;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CROSSES, GENETIC; DNA DAMAGE; DOXORUBICIN; ETOPOSIDE; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; TUMOR SUPPRESSOR PROTEIN P53; WHOLE-BODY IRRADIATION;

EID: 0035138823     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. The complexity of p53 modulation: Emerging patterns from divergent signals
2. Roles for p53 in growth arrest and apoptosis: Putting on the brakes after genotoxic stress
3. The cellular response to p53: The decision between life and death
4. p53, guardian of the genome
5. Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells
6. p53 status and the efficacy of cancer therapy in vivo
7. p53, the cellular gatekeeper for growth and division
8. High levels of p53 protein in UV-irradiated normal human skin
9. p53 is required for radiation-induced apoptosis in mouse thymocytes
10. Thymocyte apoptosis induced by p53-dependent and independent pathways
11. The role of spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53 deficient mice
12. The p53 response to ionizing radiation in adult and developing murine tissues
13. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation
14. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
15. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice
16. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors
17. Hepatocarcinogenesis in p53 deficient mice
18. p53 mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors
19. Tumor suppressor genes in rodent lung carcinogenesis-mutation of p53 does not appear to be an early lesion in lung tumor pathogenesis
20. The p53 pathway
21. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
22. p53 and response to chemotherapy and radiotherapy
23. Tumor-suppressor p53: Implications for tumor development and prognosis
24. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
25. The clinical significance of p53 aberrations in human tumours
26. Normal meiotic recombination in p53-deficient mice
27. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
28. Response of mouse skin tumors to doxorubicin is dependent on carcinogen exposure
29. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cyclopropyldibenzosuberane modulator, LY335979
30. Cure of multidrug-resistant human B-cell lymphoma xenografts by combinations of anti-B4-blocked ricin and chemotherapeutic drugs
31. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
32. DNA strand breaks: The DNA template alterations that trigger p53-dependent DNA damage response pathways
33. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents
34. p53 induction, cell cycle checkpoints, and apoptosis in DNAPK deficient scid mice
35. DNA double-strand breaks, p53, and apoptosis during lymphomagenesis in scid/scid mice
36. Effects of p53 mutations on apoptosis in mouse intestinal and human colonic adenomas
37. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene
38. Tumor spectrum analysis in p53-mutant mice
39. p53 deficient mice are extremely susceptible to radiation-induced tumorigenesis
40. p53 mutations in C57BL/6J murine thymic lymphomas induced by γ-irradiation and N-methylnitrosourea
41. Tumorigenesis in the multiple intestinal neoplasia mouse: Redundancy of negative regulators and specificity of modifiers
42. Mutational and LOH analysis of p53 alleles in colon tumors induced by 1,2-dimethylhydrazine in FI hybrid mice
43. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability
44. Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53
45. Infrequent p53 mutations in 7,12-dimethylbenz[a] anthracene-induced mammary tumors in Balb/c and p53 hemizygous mice
46. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development
47. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice
48. p53 deficiency in liver reduces local control of survival and proliferation, but does not affect apoptosis after DNA damage
49. One decade of comparative molecular carcinogenesis
50. Wild-type function of the p53 tumor suppressor protein is not required for apoptosis of mouse hepatoma cells